Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Behind the paper: stepping up to the antiplatelet.

× No keyword cloud information.

8 in total

1. Pharmacokinetics of clopidogrel after administration of a high loading dose.

Authors: Dirk Taubert; Adnan Kastrati; Steffi Harlfinger; Olga Gorchakova; Andreas Lazar; Nicolas von Beckerath; Albert Schömig; Edgar Schömig
Journal: Thromb Haemost Date: 2004-08 Impact factor: 5.249

2. Effects of CYP2C19 genotype on outcomes of clopidogrel treatment.

Authors: Guillaume Paré; Shamir R Mehta; Salim Yusuf; Sonia S Anand; Stuart J Connolly; Jack Hirsh; Katy Simonsen; Deepak L Bhatt; Keith A A Fox; John W Eikelboom
Journal: N Engl J Med Date: 2010-08-29 Impact factor: 91.245

3. The effect of CYP2C19 polymorphism on the pharmacokinetics and pharmacodynamics of clopidogrel: a possible mechanism for clopidogrel resistance.

Authors: K A Kim; P W Park; S J Hong; J-Y Park
Journal: Clin Pharmacol Ther Date: 2008-03-05 Impact factor: 6.875

4. Cytochrome P-450 polymorphisms and response to clopidogrel.

Authors: Dirk Taubert; Heleen J Bouman; Jochem W van Werkum
Journal: N Engl J Med Date: 2009-05-21 Impact factor: 91.245

5. Paraoxonase-1 is a major determinant of clopidogrel efficacy.

Authors: Heleen J Bouman; Edgar Schömig; Jochem W van Werkum; Janna Velder; Christian M Hackeng; Christoph Hirschhäuser; Christopher Waldmann; Hans-Günther Schmalz; Jurriën M ten Berg; Dirk Taubert
Journal: Nat Med Date: 2010-12-19 Impact factor: 53.440

6. Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial.

Authors: Nicolas von Beckerath; Dirk Taubert; Gisela Pogatsa-Murray; Edgar Schömig; Adnan Kastrati; Albert Schömig
Journal: Circulation Date: 2005-10-31 Impact factor: 29.690

7. Cytochrome p-450 polymorphisms and response to clopidogrel.

Authors: Jessica L Mega; Sandra L Close; Stephen D Wiviott; Lei Shen; Richard D Hockett; John T Brandt; Joseph R Walker; Elliott M Antman; William Macias; Eugene Braunwald; Marc S Sabatine
Journal: N Engl J Med Date: 2008-12-22 Impact factor: 91.245

8. Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel.

Authors: J T Brandt; S L Close; S J Iturria; C D Payne; N A Farid; C S Ernest; D R Lachno; D Salazar; K J Winters
Journal: J Thromb Haemost Date: 2007-09-26 Impact factor: 5.824

8 in total